Dysport is Ipsen’s abobotulinumtoxinA (commercialised by Galderma), an FDA-approved botulinum toxin type A supplied as a lyophilised 500 U vial with human serum albumin 125 mcg and lactose 2.5 mg, reconstituted with preservative-free saline before injection. Its Speywood-style potency units are specific to Dysport and are not interchangeable with other toxins. Professional use only.
What is Dysport 500 U?
Dysport is Ipsen’s abobotulinumtoxinA (commercialised by Galderma), a botulinum toxin type A supplied as a lyophilised 500 U vial with human serum albumin and lactose. It is reconstituted with preservative-free saline before injection. Its Speywood-style units are specific to Dysport. Potency units are specific to this product and are not interchangeable with other botulinum toxin products.
How does Dysport compare with BOTOX?
Dysport is an FDA-approved abobotulinumtoxinA. Its units are not interchangeable with BOTOX or Xeomin units — each product’s potency is defined by its own assay. Its formulation uses lactose, distinguishing it from albumin-plus-saline toxins.
| Dysport | Ipsen · lyophilised · FDA-approved · 500 U |
|---|---|
| BOTOX | Allergan · vacuum-dried · FDA-approved · 50 U |
| Xeomin | Merz · free of complexing proteins · FDA-approved · 100 U |
What do clinics use Dysport for?
Clinics select Dysport for facial expression-line work per its labelling. Dosing and technique are product-specific and decided by the treating clinician; Dysport units are not converted 1:1 to other toxins.
Commonly selected for
- Practices standardised on Dysport units
- Larger 500 U caseloads
- Aesthetic expression-line protocols
- Clinics wanting an FDA-approved branded toxin
How is Dysport supplied?
One 500 U lyophilised single-use vial. Reconstitute with preservative-free 0.9% saline immediately before use and follow the manufacturer’s handling instructions.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | Dysport® (Ipsen / Galderma) |
|---|---|
| Manufacturer | Ipsen Biopharmaceuticals, Inc. |
| Origin | France / United Kingdom |
| Active | AbobotulinumtoxinA (500 U) |
| Composition | AbobotulinumtoxinA (Clostridium botulinum type A toxin-haemagglutinin complex); with human serum albumin 125 mcg and lactose 2.5 mg per vial |
| Units | 500 U |
| Format | 500 U lyophilised single-use vial |
| Areas | Facial expression lines (aesthetic use) |
| Delivery | Reconstitute with preservative-free 0.9% saline; inject intramuscularly per the practitioner’s protocol |
| Regulatory | AbobotulinumtoxinA (Dysport) is approved by the U.S. FDA. Regulatory status of any particular market pack should be confirmed by the buyer for their jurisdiction. |
| Administration | Injectable — by a qualified medical professional only |
| Storage & handling | Store refrigerated (2–8 °C) per the manufacturer’s instructions. |
Frequently asked questions
Is Dysport FDA-approved?
Yes. AbobotulinumtoxinA (Dysport) is approved by the U.S. FDA. Confirm the regulatory status of a specific market pack for your jurisdiction.
Are Dysport units the same as BOTOX units?
No. Dysport units are product-specific and are not interchangeable 1:1 with BOTOX, Xeomin or Korean-toxin units.
What is in the vial?
AbobotulinumtoxinA with human serum albumin 125 mcg and lactose 2.5 mg.
How is it supplied?
As one lyophilised 500 U single-use vial, reconstituted with preservative-free 0.9% saline before use.
Who makes Dysport?
It is manufactured by Ipsen and commercialised in aesthetics by Galderma.